Navigation Links
Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals
Date:5/25/2009

UPPSALA, Sweden, May 25 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST). Under the agreement, Beactica will use its Sprint(TM) surface plasmon resonance (SPR)-integrated drug discovery platform to target multi-component proteins from pathogenic bacteria of interest to Cubist. Financial terms of the agreement were not disclosed.

"We are pleased to be working with Cubist in their quest to develop next-generation anti-bacterials" said Beactica CEO, Dr Per Kallblad. "Cubist has excellent strengths in the area and it is a source of pride to have been selected to help progress one of their discovery programmes."

Cubist becomes the fifth life-science company to enter an agreement with Beactica in the past eighteen months.

About Beactica

Beactica AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics. Beactica's Sprint(TM) drug discovery platform efficiently integrates surface plasmon resonance (SPR) to accelerate the identification of optimal starting points and development routes for lead discovery. The company was spun out of Uppsala University in August 2006. As well as building collaborations with external companies, Beactica is progressing its own drug discovery programmes of small molecule therapeutics. For more information about Beactica, please visit http://www.beactica.com.


'/>"/>
SOURCE Beactica AB
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BioConvergence team members Curtis Strother and ... BioLogistics Summit in San Francisco earlier this month. ... IQ and IQPC, addressed the increasingly complex logistical ... attributed to current trends of globalization, outsourcing, and ... is an increase in movement, which is often ...
(Date:6/19/2013)... Diego, CA (PRWEB) June 19, 2013 ... pipettes, Pipette.com is now stocked with Simport’s Dropette® ... all aimed at the customer doing basic biology, chemistry ... work, and serology). , For over 35 years, Simport ... disposable plastic labware - products like the Simport Dropette®. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 ExakTime, ... in North America, has introduced AccountLinx Plus, a ... payroll records between ExakTime’s software and industry-leading payroll ... software setup and keeps employee databases up-to-date in ... a business’ current payroll software, directly into ExakTime’s ...
(Date:6/18/2013)... 2013 Nasseo, Inc. today announces that ... out of hundreds of applicants by the Arizona ... Innovation Challenge . The Arizona Innovation Challenge (AIC) awards ... commercialization challenge, granting a financial award to what it ... Nasseo’s state of the art dental and orthopedic implant ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... JERSEY CITY, New Jersey, October 29, Rosetta Genomics ... of microRNA-based diagnostics, announced today its,management will present ... 3-4, 2008 at the Waldorf-Astoria Hotel in New ... recently discovered, naturally occurring, small,RNAs that act as ...
... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... financial results for the quarter,ended September 30, 2008., ... net revenue of,$438.8 million compared to net revenue of ... increase was primarily due to $118.7 million,of incremental revenue ...
... Oct. 29 The Healthcare Scoop,( http://www.healthcarescoop.com ... patient stories about healthcare, will now extend ... organizations, according,to MaryAnn Stump, president, Consumer Aware. ... including Courage Center, Mayo,Clinic, The Emily Program, ...
Cached Biology Technology:Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Inverness Medical Innovations Announces Third Quarter 2008 Results 2Inverness Medical Innovations Announces Third Quarter 2008 Results 3Inverness Medical Innovations Announces Third Quarter 2008 Results 4Inverness Medical Innovations Announces Third Quarter 2008 Results 5Inverness Medical Innovations Announces Third Quarter 2008 Results 6Inverness Medical Innovations Announces Third Quarter 2008 Results 7Inverness Medical Innovations Announces Third Quarter 2008 Results 8Inverness Medical Innovations Announces Third Quarter 2008 Results 9Inverness Medical Innovations Announces Third Quarter 2008 Results 10Inverness Medical Innovations Announces Third Quarter 2008 Results 11Inverness Medical Innovations Announces Third Quarter 2008 Results 12Inverness Medical Innovations Announces Third Quarter 2008 Results 13Inverness Medical Innovations Announces Third Quarter 2008 Results 14Inverness Medical Innovations Announces Third Quarter 2008 Results 15Inverness Medical Innovations Announces Third Quarter 2008 Results 16Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 2Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 3
(Date:6/19/2013)... canary seeds bred specifically for human consumption qualifies as ... with celiac disease (CD), scientists have confirmed in a ... Food Chemistry . , Joyce Irene Boye and ... in the United States alone have CD. They develop ... and other grains that contain gluten-related proteins. Boye,s team ...
(Date:6/19/2013)... In fall 2012, the European Medicines Agency (EMA) ... the first ever gene therapy for clinical use ... company, had developed AAV-LPL S447X for the treatment ... lipase deficiency (LPLD) which affects approximately one or ... causes severe, life-threatening inflammations of the pancreas. Afflicted ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... of cardiac therapeutics have long looked to the future when ... one,s own heart cells. A study published in the February ... American Heart Association, shows that heart stem cells from children ... heart in an animal model. ...
... of Exeter has revealed that couples with similar personalities make ... least in the world of zebra finches. Researchers found ... a willingness to explore, did a much better job of ... were markedly different in personality, chicks didn,t fare as well ...
... For the first time, scientists have mapped the genome--the genetic ... efforts to maintain the genetic diversity of captive and wild ... be used to help improve our understanding of the evolution ... National Science Foundation, the orangutan study appears in the Jan. ...
Cached Biology News:Using a child's own stem cells to repair their heart looks promising 2Opposites may attract, but they don't make better parents 2Scientists determine what makes an orangutan an orangutan 2Scientists determine what makes an orangutan an orangutan 3
... Ideal for staining westerns and includes stickers ... Pour spouts in each corner facilitate pouring ... be used for identification. Lid is designed ... for staining several gels simultaneously. Lid also ...
... 20 years of experience in providing versatile ... the Freedom EVO platform delivers even more ... future needs. Together with the new easy-to-use ... to successfully operate genomics, proteomics, and drug ...
... in any standard fixed-angle microcentrifuge rotor ... g.,Spin- centrifuge tube filters consist of ... centrifuge tube. They filter by centrifugation ... sample preparation, removal of cells from ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Material: polystyrene flat ...
Biology Products: